| Literature DB >> 19103472 |
Adrianos Nezos1, Nikolaos Pissimisis, Peter Lembessis, Antigone Sourla, Peter Dimopoulos, Theodore Dimopoulos, Kostantinos Tzelepis, Michael Koutsilieris.
Abstract
The methods employed for the detection of circulating bladder cancer cells (CBCs) and their use as a molecular staging tool in clinical settings are thoroughly reviewed. CBC isolation and enrichment methods are discussed according to their advantages and pitfalls along with the clinical data of PCR-based techniques used for CBC detection. In addition, we review the specificity of molecular markers that have been proposed so far for CBC identification, and we comment on the controversial clinical data, proposing laboratory approaches which may improve the clinical significance of CBC detection in bladder cancer.Entities:
Mesh：
Substances：
Year: 2008 PMID： 19103472 DOI： 10.1016/j.ctrv.2008.11.003
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111